| The chemistry and biology of soluble guanylate cyclase stimulators and activators M Follmann, N Griebenow, MG Hahn, I Hartung, FJ Mais, J Mittendorf, ... Angewandte Chemie International Edition 52 (36), 9442-9462, 2013 | 234 | 2013 |
| S3-leitlinie–kolorektales karzinom W Schmiegel, B Buchberger, M Follmann, U Graeven, V Heinemann, ... Zeitschrift für Gastroenterologie 55 (12), 1344-1498, 2017 | 191 | 2017 |
| Discovery of the soluble guanylate cyclase stimulator vericiguat (BAY 1021189) for the treatment of chronic heart failure M Follmann, J Ackerstaff, G Redlich, F Wunder, D Lang, A Kern, P Fey, ... Journal of medicinal chemistry 60 (12), 5146-5161, 2017 | 186 | 2017 |
| Soluble guanylate cyclase stimulators and activators P Sandner, DP Zimmer, GT Milne, M Follmann, A Hobbs, JP Stasch Reactive oxygen species: Network pharmacology and therapeutic applications …, 2021 | 170 | 2021 |
| Interdisciplinary screening, diagnosis, therapy and follow-up of breast cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017)–Part … A Wöckel, J Festl, T Stüber, K Brust, M Krockenberger, PU Heuschmann, ... Geburtshilfe und Frauenheilkunde 78 (11), 1056-1088, 2018 | 138 | 2018 |
| Discovery and pharmacological characterization of a novel potent inhibitor of diacylglycerol‐sensitive TRPC cation channels T Maier, M Follmann, G Hessler, HW Kleemann, S Hachtel, B Fuchs, ... British Journal of Pharmacology 172 (14), 3650-3660, 2015 | 122 | 2015 |
| Reporting standards for guideline-based performance measures M Nothacker, T Stokes, B Shaw, P Lindsay, R Sipilä, M Follmann, I Kopp, ... Implementation science 11, 1-11, 2015 | 91 | 2015 |
| Substituted 6-fluoro-1H-pyrazolo [4, 3-b] pyridines and use thereof M Follmann, JP Stasch, G Redlich, J Ackerstaff, N Griebenow, A Knorr, ... US Patent 9,309,239, 2016 | 80 | 2016 |
| S2k guidelines for cutaneous basal cell carcinoma–part 2: treatment, prevention and follow‐up BM Lang, P Balermpas, A Bauer, A Blum, GF Brölsch, T Dirschka, ... JDDG: Journal der Deutschen Dermatologischen Gesellschaft 17 (2), 214-230, 2019 | 77 | 2019 |
| Metamizole/dipyrone for the relief of cancer pain: A systematic review and evidence-based recommendations for clinical practice J Gaertner, UM Stamer, C Remi, R Voltz, C Bausewein, R Sabatowski, ... Palliative medicine 31 (1), 26-34, 2017 | 74 | 2017 |
| S2k guidelines for cutaneous basal cell carcinoma–part 1: epidemiology, genetics and diagnosis BM Lang, P Balermpas, A Bauer, A Blum, GF Brölsch, T Dirschka, ... JDDG: Journal der Deutschen Dermatologischen Gesellschaft 17 (1), 94-103, 2019 | 70 | 2019 |
| Substituted 5-fluoro-1H-pyrazolopyridines and their use M Follmann, JP Stasch, G Redlich, J Ackerstaff, N Griebenow, W Kroh, ... US Patent 8,420,656, 2013 | 64 | 2013 |
| Soluble GC stimulators and activators: Past, present and future P Sandner, M Follmann, E Becker‐Pelster, MG Hahn, C Meier, C Freitas, ... British journal of pharmacology, 2021 | 63 | 2021 |
| Bicyclic aza heterocycles, and use thereof M Follmann, JP Stasch, G Redlich, J Ackerstaff, N Griebenow, A Knorr, ... US Patent 9,096,592, 2015 | 63 | 2015 |
| S3-Leitlinie zum exokrinen Pankreaskarzinom T Seufferlein, M Porzner, T Becker, V Budach, G Ceyhan, I Esposito, ... Zeitschrift für Gastroenterologie 51 (12), 1395-1440, 2013 | 61 | 2013 |
| An approach towards enhancement of a screening library: The Next Generation Library Initiative (NGLI) at Bayer—against all odds? M Follmann, H Briem, A Steinmeyer, A Hillisch, MH Schmitt, H Haning, ... Drug Discovery Today 24 (3), 668-672, 2019 | 55 | 2019 |
| Model Studies Towards Azadirachtin: Part 2. Construction of the Crowded C8 C14 Bond by Transition Metal Chemistry KC Nicolaou, AJ Roecker, M Follmann, R Baati Angewandte Chemie 114 (12), 2211-2214, 2002 | 49 | 2002 |
| Hodgkin lymphoma in adults: diagnosis, treatment, and follow-up PJ Bröckelmann, DA Eichenauer, T Jakob, M Follmann, A Engert, ... Deutsches Ärzteblatt International 115 (31-32), 535, 2018 | 48 | 2018 |
| The diagnosis, treatment, and follow-up of renal cell carcinoma C Doehn, V Grünwald, T Steiner, M Follmann, H Rexer, S Krege Deutsches Ärzteblatt International 113 (35-36), 590, 2016 | 47 | 2016 |
| Substituted 5-fluoro-1h-pyrazolopyridines and use thereof M Follmann, JP Stasch, G Redlich, J Ackerstaff, N Griebenow, W Kroh, ... | 47 | 2014 |
